{"id":"F2008L00385","name":"Therapeutic Goods (Listing) Notice 2008 (No. 2)","slug":"therapeutic-goods-listing-notice-2008-no-2","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":72620,"registerId":"commonwealth-F2008L00385-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2008 (No. 2)","content":"![](image.001.png)\n\nTherapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2008 (No. 2)\n\nI, ROHAN HAMMETT, National Manager, Therapeutic Goods Administration, and the delegate of the Minister for Health and Ageing for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (ARTG) for listed goods:\n\n-   preparations, referred to in Item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations 1990, for oral use that contain, as their therapeutically active ingredient, Euphausia superba oil, being a substance that is to be mentioned in Division 1 of Part 5 of Schedule 4 of the Therapeutic Goods Regulations 1990.\n\nThis Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nPursuant to subsection 9A(6) of the Act this Notice ceases to have effect on the day that amendments to the Therapeutic Goods Regulations 1990 come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the ARTG for listed goods.\n\nDated this 4th day of February 2008\n\nDr Rohan Hammett\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2293},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The instrument maintains its narrow, original purpose. It temporarily lists a specific ingredient (krill oil) for oral use pending regulatory amendment, without expanding to other substances or administration routes."},"complexity_factors":["Single operative provision targeting one specific substance (Euphausia superba oil)","Automatic repeal mechanism triggered by future amendment to the Therapeutic Goods Regulations 1990","Reliance on external definitions in Schedule 4 of the Regulations for 'listed goods' and permitted ingredients"],"plain_english_summary":"This notice temporarily permits oral krill oil (Euphausia superba) supplements to be sold in Australia by allowing them to be entered on the ARTG as listed goods. It affects manufacturers, importers and consumers by keeping capsules, tablets and liquids available while the government amends the Therapeutic Goods Regulations to permanently approve krill oil as an ingredient."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2008-no-2","history":"/api/acts/therapeutic-goods-listing-notice-2008-no-2/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2008-no-2/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2008-no-2/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2008-no-2/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2008-no-2/documents"}}